Jesse O’Shea

834 total citations
20 papers, 308 citations indexed

About

Jesse O’Shea is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Jesse O’Shea has authored 20 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Infectious Diseases and 10 papers in Virology. Recurrent topics in Jesse O’Shea's work include HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (5 papers) and Herpesvirus Infections and Treatments (5 papers). Jesse O’Shea is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (5 papers) and Herpesvirus Infections and Treatments (5 papers). Jesse O’Shea collaborates with scholars based in United States, Australia and Uganda. Jesse O’Shea's co-authors include John T. Brooks, John Weiser, Thomas D. Filardo, Sapna Bamrah Morris, Brett W. Petersen, Nadine Rouphael, Mark R. Prausnitz, Vincent C. Marconi, Abeer Moanna and Christina Gavegnano and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Journal of General Internal Medicine.

In The Last Decade

Jesse O’Shea

14 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesse O’Shea United States 7 118 109 106 103 34 20 308
Melania Degli Antoni Italy 10 89 0.8× 139 1.3× 76 0.7× 85 0.8× 20 0.6× 24 302
Brandon Fombuena Canada 11 102 0.9× 167 1.5× 86 0.8× 173 1.7× 29 0.9× 19 430
Andrés Esteban-Cantos Spain 10 100 0.8× 88 0.8× 88 0.8× 53 0.5× 4 0.1× 14 253
Emma Recio‐Fernández Spain 10 47 0.4× 124 1.1× 58 0.5× 168 1.6× 4 0.1× 16 272
Ivan Schietroma Italy 12 138 1.2× 96 0.9× 73 0.7× 157 1.5× 4 0.1× 12 347
Monray Edward Williams South Africa 11 145 1.2× 59 0.5× 39 0.4× 67 0.7× 7 0.2× 29 234
Ivana Grgić Croatia 11 33 0.3× 93 0.9× 212 2.0× 41 0.4× 11 0.3× 21 356
Elisabet Deig Spain 6 126 1.1× 120 1.1× 57 0.5× 27 0.3× 5 0.1× 12 258
Margaret Wecker United States 7 60 0.5× 90 0.8× 119 1.1× 89 0.9× 1 0.0× 9 364
M. Fröschl Germany 6 27 0.2× 126 1.2× 112 1.1× 13 0.1× 7 0.2× 13 227

Countries citing papers authored by Jesse O’Shea

Since Specialization
Citations

This map shows the geographic impact of Jesse O’Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse O’Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse O’Shea more than expected).

Fields of papers citing papers by Jesse O’Shea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse O’Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse O’Shea. The network helps show where Jesse O’Shea may publish in the future.

Co-authorship network of co-authors of Jesse O’Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse O’Shea. A scholar is included among the top collaborators of Jesse O’Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse O’Shea. Jesse O’Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bourdeau, Beth, Greg Rebchook, Starley B. Shade, et al.. (2025). Innovative administration of long-acting injectables for HIV treatment enhancement at home (INVITE-HOME): implementation science study protocol. BMJ Open. 15(8). e097921–e097921.
3.
Zhu, Weiming, Patricia Bessler, Allison Lale, et al.. (2025). Real-World Positive Predictive Value and False Positive Rates of Laboratory-Based HIV Antigen/Antibody Testing by Age and Sex — United States, 2019–2024. JAIDS Journal of Acquired Immune Deficiency Syndromes.
4.
Viguerie, Alex, Jesse O’Shea, Marie Johnston, et al.. (2025). Impact of increased uptake of long-acting injectable antiretroviral therapy on HIV incidence and viral suppression in the United States under 2021 FDA guidelines. AIDS. 39(8). 1024–1031. 1 indexed citations
5.
O’Shea, Jesse, Xin Yuan, Kate Buchacz, et al.. (2025). Brief Report: Barriers to Rapid Enrollment and ART Initiation Among US HIV Care Facilities. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(5). 449–454.
6.
O’Shea, Jesse, et al.. (2023). HIV and mpox: a rapid review. AIDS. 37(14). 2105–2114. 2 indexed citations
7.
Brooks, John T., Mary G. Reynolds, Elizabeth Torrone, et al.. (2023). How the Orthodox Features of Orthopoxviruses Led to an Unorthodox Mpox Outbreak: What We’ve Learned, and What We Still Need to Understand. The Journal of Infectious Diseases. 229(Supplement_2). S121–S131. 1 indexed citations
8.
Philpott, David, Robert A. Bonacci, Paul J. Weidle, et al.. (2023). Low CD4 Count or Being Out of Care Increases the Risk for Mpox Hospitalization Among People With Human Immunodeficiency Virus and Mpox. Clinical Infectious Diseases. 78(3). 651–654. 7 indexed citations
9.
O’Shea, Jesse, Jason Zucker, Samuel D. Stampfer, et al.. (2023). Prolonged Mpox Disease in People With Advanced HIV: Characterization of Mpox Skin Lesions. The Journal of Infectious Diseases. 229(Supplement_2). S243–S248. 6 indexed citations
10.
O’Shea, Jesse, et al.. (2023). Considerations for long-acting antiretroviral therapy in older persons with HIV. AIDS. 37(15). 2271–2286. 6 indexed citations
11.
O’Shea, Jesse, Robyn Neblett Fanfair, Tiffany J. Williams, et al.. (2023). The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression Assessment. JAIDS Journal of Acquired Immune Deficiency Syndromes. 93(2). 134–142. 1 indexed citations
12.
O’Shea, Jesse, Nora Oliver, & Emily J. Cartwright. (2022). Diagnosis and Clinical Manifestations of Acute Hepatitis C Infection in People Living with HIV. AIDS Patient Care and STDs. 36(5). 172–177. 1 indexed citations
13.
O’Shea, Jesse, Julia W. Gallini, Xiangqin Cui, Abeer Moanna, & Vincent C. Marconi. (2022). Rapid Antiretroviral Therapy Program: Development and Evaluation at a Veterans Affairs Medical Center in the Southern United States. AIDS Patient Care and STDs. 36(6). 219–225. 13 indexed citations
14.
O’Shea, Jesse, Thomas D. Filardo, Sapna Bamrah Morris, et al.. (2022). Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022. MMWR Morbidity and Mortality Weekly Report. 71(32). 1023–1028. 93 indexed citations
15.
O’Shea, Jesse, Robyn Neblett Fanfair, Sharoda Dasgupta, et al.. (2022). Cisgender women with HIV in the United States: how have HIV care continuum outcomes changed over time? 2015–2020. AIDS. 37(2). 347–353. 1 indexed citations
16.
O’Shea, Jesse, Mark R. Prausnitz, & Nadine Rouphael. (2021). Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks. Vaccines. 9(4). 320–320. 44 indexed citations
17.
O’Shea, Jesse, et al.. (2020). Population-Based Standing Orders: a Novel Approach to Hepatitis C Screening. Journal of General Internal Medicine. 36(2). 538–539. 1 indexed citations
18.
Titanji, Boghuma K, Monica M. Farley, Abeer Moanna, et al.. (2020). Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019. Clinical Infectious Diseases. 72(7). 1247–1250. 92 indexed citations
19.
Chaunzwa, Tafadzwa L., et al.. (2018). Hemolytic Anemia and Gastric Carcinoid in a Russian Seafarer: Highlighting the Role of Diagnostic Technologies in Modern Clinical Practice.. PubMed. 91(3). 243–246.
20.
Tapsell, Linda C, Marijka Batterham, Xu‐Feng Huang, et al.. (2009). Short term effects of energy restriction and dietary fat sub-type on weight loss and disease risk factors. Nutrition Metabolism and Cardiovascular Diseases. 20(5). 317–325. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melania Degli Antoni Breakdown of academic impact, for papers by Brandon Fombuena Breakdown of academic impact, for papers by Andrés Esteban-Cantos Breakdown of academic impact, for papers by Emma Recio‐Fernández Breakdown of academic impact, for papers by Ivan Schietroma Breakdown of academic impact, for papers by Monray Edward Williams Breakdown of academic impact, for papers by Ivana Grgić Breakdown of academic impact, for papers by Elisabet Deig Breakdown of academic impact, for papers by Margaret Wecker Breakdown of academic impact, for papers by M. Fröschl
Rankless by CCL
2026